Effectiveness of antenatal steroids in obstetric subgroups

Obstetrics and Gynecology

Volumn 93, Issue 2, 1999, Pages 174-179

  Elimian, Andrew ^a   Verma, Uma ^a   Canterino, Joseph ^a   Shah, Jalpa ^a   Visintainer, Paul ^a   Tejani, Nergesh ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; ENCEPHALOMALACIA; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN MORTALITY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; STEROID THERAPY;

APGAR SCORE; BETAMETHASONE; BIRTH WEIGHT; CEREBRAL HEMORRHAGE; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; INFANT MORTALITY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LEUKOMALACIA, PERIVENTRICULAR; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TREATMENT OUTCOME;

EID: 0033081023     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00400-1     Document Type: Article

References (22)

1. National Institutes of Health. Report of the Consensus Development Conference on the effect of corticosteroids for fetal maturation on perinatal outcomes. National Institute of Child Health and Human Development. NIH publication no. 95-3784. Bethesda, Maryland: National Institutes of Health, November 1994.
2. Gardner M.O., Papile L.A., Wright L.L. Antenatal corticosteroids in pregnancies complicated by preterm premature rupture of membranes. Obstet Gynecol. 90:1997;851-853.
3. Brenner W.E., Edelman D.A., Hendricks C.H. A standard of fetal growth for the United States of America. Am J Obstet Gynecol. 126:1976;555-564.
4. Papile L.A., Burstein J., Koffier H. Incidence and evolution of subependymal and intraventricular hemorrhage A study of infants with birthweights less than 1500 gm . J Pediatr. 92:1978;529-534.
5. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 50:1972;515-525.
6. Collaborative Group on Antenatal Steroid Therapy . Effect of antenatal dexamethasone administration on prevention of respiratory distress syndrome. Am J Obstet Gynecol. 141:1981;276-287.
7. Taeusch H.W., Frigoletto F., Kitzmiller J., Avery M.E., Hehre A., Fromm B., et al. Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics. 63:1979;64-72.
8. Doran T.A., Swyer P., MacMurray B., Mahon W., Enhorhing G., Bernstein A., et al. Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome. Am J Obstet Gynecol. 136:1980;313-320.
9. Gamsu H.R., Mullinger B.M., Donnai P., Dash C.H. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants Report of a UK multicentre trial . Br J Obstet Gynaecol. 96:1989;401-410.
10. Block M.F., Kling O.R., Crosby W.M. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant. Obstet Gynecol. 50:1977;186-190.
11. Garite T.J., Freeman R.K., Linzey E.M., Braly P.S., Dorchester W.L. Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation. Am J Obstet Gynecol. 141:1981;508-515.
12. Iams J.D., Talbert M.L., Barrows H., Sachs L. Management of preterm prematurely ruptured membranes A prospective randomized comparison of observation versus use of steroids and timed delivery . Am J Obstet Gynecol. 151:1985;32-38.
13. Nelson L.H., Meis P.J., Hatjis C.G., Ernest J.M., Dillard R., Schey H.M. Premature rupture of membranes A prospective, randomized evaluation of steroids, latent phase, and expectant management . Obstet Gynecol. 66:1985;55-58.
14. Papageorgiou A.N., Desgranges M.F., Masson M., Colle E., Shatz R., Gelfand M.M. The antenatal use of betamethasone in the prevention of respiratory distress syndrome A controlled double-blind study . Pediatrics. 63:1979;73-79.
15. Crowley P. Corticosteroids after preterm premature rupture of membranes. Obstet Gynecol Clin North Am. 19:1992;317-326.
16. Morales W.J., Diebel D., Lazar A.J., Zadrozny D. The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of membranes. Am J Obstet Gynecol. 154:1986;591-595.
17. Ruvinsky E.D., Douvas S.G., Roberts W.E., Martin J.N. Jr, Palmer S.M., Rhodes P.G., et al. Maternal administration of dexamethasone in severe pregnancy-induced hypertension. Am J Obstet Gynecol. 149:1984;722-726.
18. Ricke P.S., Elliot J.P., Freeman R.K. Use of corticosteroids in pregnancy induced hypertension. Obstet Gynecol. 55:1980;206-210.
19. Lamont R.F., Dunlop P.D.M., Levene M.I., Elder M.G. Use of glucocorticoids in pregnancies complicated by severe hypertension and proteinuria. Br J Obstet Gynaecol. 90:1983;199-202.
20. Elliott J.P., O'Keefe D.F., Greenberg P., Freeman R.K. Pulmonary edema associated with magnesium sulfate and betamethasone administration. Am J Obstet Gynecol. 134:1979;717-719.
21. Economides D.L., Nicolaides K.H., Linton E.A., Perry L.A., Chard T. Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Ther. 3:1988;158-164.
22. Procianoy R.S., Garcia-Prats J.A., Adams J.M., Silvers A., Rudolph A.J. Hyaline membrane disease and intraventricular hemorrhage in small for gestational age infants. Arch Dis Child. 55:1980;502-505.